NICE INSIGHT REPORT
Mammalian Cell Culture, Biologics:Market Insight, CDMO Pricing and Competitor Benchmarking
Updated Monthly
2025 CDMO pricing data for 105 clinical and commercial mammalian biologics development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 77 biologics CDMOs specializing in mammalian cell culture
Technical focus on emerging antibody formats, with an in-depth look at the growing pace of bispecific antibody clinical trials
Includes Nice Insight's Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mammalian biologics trials, sourced from the FDA Clinical Trials Database
Key market insights for innovators, CDMOs, and investors in the mammalian biologics industry. Mix and match subscriptions to fit your organization's goals.
Trends & Opinions
Immediate access to Nice Insight's Mammalian Biologics Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
Clinical Trials Landscape
Access to Nice Insight's Mammalian Biologics Clinical Trials report, plus access to our multi-modality Clinical Trial Landscape tool — an in-depth, interactive study of current and upcoming mammalian biologics trials.
Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.
Master the Mammalian Biologics Market, Preclinical through Commercial:
Competitive Benchmkaring
85+ Mammalian CDMO Profiles
Over 1,000 hours of data collection and analysis —
including interviews with CDMO owners, PhDs and customers.
